Crossmark

Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.07.019

Published Print: 2017-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Roviello, Giandomenico https://orcid.org/0000-0001-5504-8237
Generali, Daniele
License Information

Text and Data Mining valid from 2017-12-01
More Information

This article is maintained by: Elsevier

Article Title: Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.07.019

Content Type: simple-article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below